3,519 Shares in HCA Healthcare, Inc. (NYSE:HCA) Purchased by SteelPeak Wealth LLC

SteelPeak Wealth LLC bought a new stake in HCA Healthcare, Inc. (NYSE:HCA) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 3,519 shares of the company’s stock, valued at approximately $1,056,000.

Other institutional investors have also bought and sold shares of the company. FMR LLC lifted its position in shares of HCA Healthcare by 322.3% during the third quarter. FMR LLC now owns 3,141,769 shares of the company’s stock valued at $1,276,909,000 after purchasing an additional 2,397,883 shares in the last quarter. Franklin Resources Inc. lifted its position in shares of HCA Healthcare by 11.7% during the 3rd quarter. Franklin Resources Inc. now owns 1,669,721 shares of the company’s stock worth $660,842,000 after buying an additional 174,946 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in shares of HCA Healthcare by 2.8% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,487,367 shares of the company’s stock valued at $604,511,000 after acquiring an additional 41,190 shares during the last quarter. Janus Henderson Group PLC boosted its position in HCA Healthcare by 12.0% in the third quarter. Janus Henderson Group PLC now owns 1,339,638 shares of the company’s stock worth $544,467,000 after purchasing an additional 143,995 shares during the last quarter. Finally, Nordea Investment Management AB increased its position in shares of HCA Healthcare by 29.7% during the 4th quarter. Nordea Investment Management AB now owns 843,764 shares of the company’s stock valued at $253,020,000 after purchasing an additional 193,075 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

Insider Buying and Selling at HCA Healthcare

In related news, insider Erol R. Akdamar sold 2,900 shares of the firm’s stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the sale, the insider now owns 6,843 shares of the company’s stock, valued at $2,415,579. This trade represents a 29.76 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, SVP Phillip G. Billington sold 3,897 shares of the company’s stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the transaction, the senior vice president now owns 52,702 shares of the company’s stock, valued at $18,445,700. This trade represents a 6.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.60% of the company’s stock.

HCA Healthcare Trading Down 0.3 %

Shares of HCA Healthcare stock opened at $327.80 on Thursday. The company has a 50 day simple moving average of $313.28 and a two-hundred day simple moving average of $353.27. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00. The firm has a market cap of $83.03 billion, a PE ratio of 14.72, a PEG ratio of 1.09 and a beta of 1.64. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 520.98% and a net margin of 8.52%. During the same quarter last year, the company earned $5.90 earnings per share. Analysts expect that HCA Healthcare, Inc. will post 21.75 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be issued a dividend of $0.72 per share. The ex-dividend date is Monday, March 17th. This represents a $2.88 annualized dividend and a dividend yield of 0.88%. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s dividend payout ratio (DPR) is currently 11.85%.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on HCA. KeyCorp decreased their price objective on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a report on Tuesday, January 7th. Royal Bank of Canada dropped their price objective on HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating on the stock in a research note on Monday. Wells Fargo & Company lowered HCA Healthcare from an “equal weight” rating to an “underweight” rating and lowered their target price for the company from $400.00 to $320.00 in a research note on Monday, November 25th. Raymond James cut HCA Healthcare from an “outperform” rating to a “market perform” rating in a research note on Friday, November 22nd. Finally, Oppenheimer lifted their target price on shares of HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a research note on Monday, October 28th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $382.19.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.